BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Treatment
234 results:

  • 1. Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis.
    Yamada K; Takeuchi M; Fukumoto T; Suzuki M; Kato A; Mizuki Y; Yamada N; Kaneko T; Mizuki N; Horita N
    Sci Rep; 2024 Apr; 14(1):7887. PubMed ID: 38570507
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. OGDH and Bcl-xL loss causes synthetic lethality in glioblastoma.
    Nguyen TT; Torrini C; Shang E; Shu C; Mun JY; Gao Q; Humala N; Akman HO; Zhang G; Westhoff MA; Karpel-Massler G; Bruce JN; Canoll P; Siegelin MD
    JCI Insight; 2024 Mar; 9(8):. PubMed ID: 38483541
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Regulation of cell Cycle Progression through RB Phosphorylation by Nilotinib and AT-9283 in Human Melanoma A375P cells.
    Pham TM; Ahmed M; Lai TH; Bahar ME; Hwang JS; Maulidi RF; Ngo QN; Kim DR
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474202
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pineal anlage tumor: clinical and diagnostic features, and rationales for treatment.
    Obrecht-Sturm D; Pfaff E; Mynarek M; Bison B; Rodehüser M; Becker M; Kietz S; Pfister SM; Jones DT; Sturm D; von Deimling A; Sahm F; Kortmann RD; Schwarz R; Pietsch T; Fleischhack G; Rutkowski S
    J Neurooncol; 2024 Jan; 166(2):359-368. PubMed ID: 38253790
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Increase in the Life Expectancy of Patients with Cancer in the United States.
    Devasia TP; Howlader N; Dewar RA; Stevens JL; Mittu K; Mariotto AB
    Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):196-205. PubMed ID: 38015774
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Sequential Rocket-Mode Bioactivating Ticagrelor Prodrug Nanoplatform Combining Light-Switchable Diphtherin Transgene System for Breast Cancer Metastasis Inhibition.
    Zou J; Sun R; He M; Chen Y; Cheng Y; Xia C; Ma Y; Zheng S; Fu X; Yuan Z; Lan M; Lou K; Chen X; Gao F
    ACS Appl Mater Interfaces; 2023 Nov; 15(46):53198-53216. PubMed ID: 37942626
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Unravelling the role of immune cells and FN1 in the recurrence and therapeutic process of skull base chordoma.
    Huo X; Ma S; Wang C; Song L; Yao B; Zhu S; Li P; Wang L; Wu Z; Wang K
    Clin Transl Med; 2023 Oct; 13(10):e1429. PubMed ID: 37784253
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Preeclampsia, antihypertensive medication use in pregnancy and risk of childhood cancer in offspring.
    Askins L; Orimoloye HT; Deng C; Hansen J; Olsen J; Ritz B; Janzen C; Heck JE
    Cancer Causes Control; 2024 Jan; 35(1):43-53. PubMed ID: 37535154
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Children's Oncology Group's 2023 blueprint for research: Neuroblastoma.
    Bagatell R; DuBois SG; Naranjo A; Belle J; Goldsmith KC; Park JR; Irwin MS;
    Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30572. PubMed ID: 37458162
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors.
    Ding L; Sun L; Bu MT; Zhang Y; Scott LN; Prins RM; Su MA; Lechner MG; Hugo W
    Front Immunol; 2023; 14():1176994. PubMed ID: 37435085
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Enhancing information on stage at diagnosis for childhood cancer in Africa.
    Liu B; Abraham N; Chitsike I; Sylvie CGL; Kambugu J; Stévy NMA; Pondy AHO; Renner L; Parkin DM
    Pediatr Blood Cancer; 2023 Oct; 70(10):e30555. PubMed ID: 37432023
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. MRI Features for Identifying
    Jansen RW; de Bloeme CM; Cardoen L; Göricke S; van Elst S; Jessen JL; Ramasubramanian A; Skalet AH; Miller AK; Maeder P; Uner OE; Hubbard GB; Grossniklaus H; Boldt HC; Nichols KE; Brennan RC; Sen S; Sirin S; Brisse HJ; Galluzzi P; Dommering CJ; Castelijns JA; van der Valk P; Boellaard R; Dorsman J; Moll AC; de Jong MC; de Graaf P
    Radiology; 2023 Jun; 307(5):e222264. PubMed ID: 37191489
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A secondary CD34+ acute lymphoblastic leukemia unmasked and mobilized by G-CSF in an autologous stem cell donor with testicular cancer.
    Cooling L; Kelley J; Sexton E; Anand S; Hoffmann S
    Transfusion; 2023 Apr; 63(4):684-689. PubMed ID: 36762622
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Acute Lymphoblastic Leukemia Developing in a Patient with 46, XY Pure Gonadal Dysgenesis (Swyer Syndrome) with Malignant Gonadal germ cell tumor: A Case Report and Literature Review.
    Zhang X; Zhang Y; Wang J; Yang J; Yu S; Yin M; Li S; Yang J
    Curr Oncol; 2022 Dec; 29(12):9753-9759. PubMed ID: 36547180
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma.
    Xie Y; Xu Z; Mei X; Shi W
    Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Changes in the Immune cell Repertoire for the treatment of Malignant Melanoma.
    Nakamura K; Okuyama R
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361781
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Towards zero percent treatment abandonment of patients with common and curable childhood cancer types in Blantyre, Malawi.
    Chakumatha E; Khofi H; Landman L; Weijers J; Bailey S; Chagaluka G; Molyneux E; Israels T
    Pediatr Blood Cancer; 2022 Dec; 69(12):e29899. PubMed ID: 35869892
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Peptide-based targeted cancer therapeutics: Design, synthesis and biological evaluation.
    Iwanov I; Rossi A; Montesi M; Doytchinova I; Sargsyan A; Momekov G; Panseri S; Naydenova E
    Eur J Pharm Sci; 2022 Sep; 176():106249. PubMed ID: 35779821
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Enrichment of cancer-predisposing germline variants in adult and pediatric patients with acute lymphoblastic leukemia.
    Douglas SPM; Lahtinen AK; Koski JR; Leimi L; Keränen MAI; Koskenvuo M; Heckman CA; Jahnukainen K; Pitkänen E; Wartiovaara-Kautto U; Kilpivaara O
    Sci Rep; 2022 Jun; 12(1):10670. PubMed ID: 35739278
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. treatment Response and Clinical Outcomes of Well-Differentiated High-Grade Neuroendocrine tumors to Lutetium-177-DOTATATE.
    Raj N; Coffman K; Le T; Do RKG; Rafailov J; Choi Y; Chou JF; Capanu M; Dunphy M; Fox JJ; Grewal RK; Reddy RP; Riedl C; Schoder H; Bodei L; Reidy-Lagunes D
    Neuroendocrinology; 2022; 112(12):1177-1186. PubMed ID: 35609558
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.